Evaluation of Efficacy and Safety of Dan’e‐Fukang Soft Extract in the Treatment of Endometriosis: A Meta‐Analysis of 39 Randomized Controlled Trials Enrolling 5442 Patients

Yantao Li, Te Li, Shilin Song
Evidence-based complementary and alternative medicine : eCAM · 2017 · vol. 2017(1) , pp. 9767391 · doi:10.1155/2017/9767391 · PMID:28337228 · PMC5350406 · W2591707299
review OA: gold CC0 ⤵ 6 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher

Abstract

Objective . To systematically evaluate the efficacy and safety of Dan’e‐fukang soft extract in endometriosis treatment. Method . PubMed, CNKI, Wanfang Database, VIP, SinoMed, and Cochrane Library were searched. Randomized controlled trials (RCTs) comparing the efficacy of Dan’e‐fukang soft extract and conventional western medicines for endometriosis treatment were included. The data were extracted independently by two people and analyzed using RevMan 5.2.0 software. The relative risk (RR) and mean difference (MD) with 95% confidence intervals were considered as effective outcome indicators. Results . Thirty‐nine papers including 5442 patients with endometriosis were included in this study. A meta‐analysis revealed that Dan’e‐fukang soft extract was more efficient than gestrinone in the treatment of endometriosis (RR = 1.08, 95% CI = 1.03 to 1.15, I 2 = 71%, REM, 18 trials) and its efficacy was comparable to that of danazol and mifepristone. Dan’e‐fukang soft extract was also as effective as gestrinone and mifepristone in terms of relapse rate and relieving dysmenorrhea. The incidence of adverse reactions was lower than that of conventional western medicines. Conclusions . The results of this study showed that Dan’e‐fukang soft extract offers certain advantages in endometriosis treatment, but rigorously designed, strictly implemented RCTs are needed to further validate its efficacy.

My notes (saved in your browser only)

Condition tags

endometriosisdysmenorrhea

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (19)

Cited by (6)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:20:31.759405+00:00
License: CC0 · commercial use OK